Clever Leaves Holdings Inc

OTCPK:CLVR

Colombia / Healthcare / Pharmaceuticals

Income Statement
Balance Sheet
Cash Flow Statement
EBITDA Reconciliation
Net Income Reconciliation
Forecasts
Valuation Ratios
Fiscal Years
Fiscal Half
Fiscal Quarters
Year To Date
Latest Twelve Months
Ascending
Descending
3 Years
5 Years
10 Years
Millions
Billions
Thousands
Ones
2020-12-31
FY-4
2021-12-31
FY-3
2022-12-31
FY-2
2023-12-31
FY-1
Loading view data...
Net Income to Stockholders
-25.9
-45.7
-66.2
-17.9
Depreciation & Amortization (CF)
3.6
3.5
3.7
2.8
Amortization of Deferred Charges (CF)
0.4
4.2
1.9
-
Stock-Based Comp
1.7
11.5
2.3
0.8
Change In Accounts Receivable
-1.1
-0.5
-0.3
1.3
Change In Inventories
-5.2
-8.2
-4.5
2.6
Change in Other Net Operating Assets
2.7
-1.4
0.5
0.2
Other Operating Activities
1.9
0.4
33.4
-1.3
Cash from Operations
-22.0
-36.2
-29.1
-11.5
Capital Expenditures
-3.7
-7.3
-1.3
0.0
Cash Acquisitions
-
-
-
-
Other Investing Activities
0.0
0.0
2.5
4.7
Cash from Investing
-3.7
-7.3
1.2
4.7
Dividends Paid (Ex Special Dividends)
-
-
-
-
Special Dividend Paid
-
-
-
-
Long-Term Debt Issued
10.7
27.9
0.1
-
Long-Term Debt Repaid
-4.2
-26.5
-23.1
-0.5
Repurchase of Common Stock
-6.3
-
-
-
Other Financing Activities
91.5
0.5
26.3
1.1
Cash from Financing
91.8
1.8
3.3
0.7
Beginning Cash (CF)
13.2
79.5
37.7
12.9
Foreign Exchange Rate Adjustments
0.1
-0.1
-0.2
0.2
Additions / Reductions
66.2
-41.7
-24.6
-6.2
Ending Cash (CF)
79.5
37.7
12.9
6.9
Levered Free Cash Flow
-25.6
-43.5
-30.4
-11.5
Cash Interest Paid
0.6
0.5
0.3
0.2
FY-4FY-3FY-2FY-101234
USD in Millions except per share data. All rights reserved. Terms Of Use

Your Toolbox To Outsmart
The Market

The video below provides an overview of the key benefits to help you get the most out of InvestingPro.